Patents by Inventor Dominic Melançon

Dominic Melançon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8629247
    Abstract: Antibodies (Ab) and antigen binding fragments capable of binding to prostate specific membrane antigen and which may be used for diagnostic and therapeutic purposes are provided herein. Formulation anti-PSMA antibodies which are stable under extreme storage condition are also provided.
    Type: Grant
    Filed: April 14, 2010
    Date of Patent: January 14, 2014
    Assignee: Proscan RX Pharma Inc.
    Inventors: Serge Moffett, Dominic Melançon, Uri H. Saragovi, Phil Gold, Claudio A. Cuello
  • Publication number: 20120093719
    Abstract: Antibodies (Ab) and antigen binding fragments capable of binding to prostate specific membrane antigen and which may be used for diagnostic and therapeutic purposes are provided herein. Formulation anti-PSMA antibodies which are stable under extreme storage condition are also provided.
    Type: Application
    Filed: April 14, 2010
    Publication date: April 19, 2012
    Applicant: PROSCAN RX PHARMA INC.
    Inventors: Serge Moffett, Dominic Melançon, Uri H. Saragovi, Phil Gold, Claudio A. Cuello
  • Publication number: 20110189093
    Abstract: Polypeptides, antibodies or antigen-binding fragments capable of binding to prostate specific membrane antigen (PSMA) are provided. These polypeptides, antibodies or antigen-binding fragments may be used for diagnostic and/or therapeutic purposes.
    Type: Application
    Filed: April 14, 2009
    Publication date: August 4, 2011
    Applicant: PROSCAN RX PHARMA
    Inventors: Serge Moffett, Dominic Melancon, Uri H. Saragovi, Phil Gold, Claudio A. Cuello